A buyer guide to longevity medicine implementation: how to judge clinic delivery, governance, AI claims, incidental findings, and follow-up before you pay.
A buyer guide to Neko Health cost, its scan-first preventive model, New York expansion, false positives, and what to ask before booking.
A buyer guide to Human Longevity exam cost, HLI-style diagnostics, genetics, full-body imaging, and the follow-up questions to ask before paying.
A 2026 buyer guide to longevity clinic follow-up plans: who owns abnormal results, what gets retested, what is included, and which red flags matter.
A decision framework for choosing executive health, concierge prevention, or a longevity clinic in 2026 based on risk profile, diagnostics, follow-up, budget, and red flags.
A cautious 2026 guide to cognitive decline, longevity clinics, brain-health tests, lifestyle evidence, referral pathways, and red flags.
A buyer's guide to full-body MRI at longevity clinics: what it can detect, what it misses, real cost models, false positives, and safer alternatives.
A buyer guide to longevity clinic blood panels: which biomarkers change decisions, which are exploratory, and what red flags to avoid before paying.
VO2 max is one of the better-supported longevity metrics, but the value depends on testing quality, medical screening, and a plan after the number.
A practical buyer’s guide to longevity health assessments: biomarkers, imaging, genetics, fitness testing, costs, and the questions to ask before booking.
A clinic announces a longevity program focused on men: coordinated assessment + roadmap + follow-up. A signal of the sector's 'productization.'
BBC examines the longevity industry boom: extreme diagnostics, expensive programs, and the key question — what part is real prevention and what part is marketing?
An inside look at Biograph: 6 hours, 30+ tests, and 1,000+ data points. The clinical question isn't 'what do you measure' — it's what decisions you change with the data.
A comprehensive review of 2025's longevity milestones: AI-driven drug deals, clinic proliferation, biomarker standardization, and the XPRIZE Healthspan competition reaching its final phase.
Longevity.Technology launches Longevity Clinics World, a directory of 350+ pre-validated clinics globally. The move signals an industry maturing from niche to mainstream.
A systematic review in Nature Metabolism concludes that clinical evidence for NAD+ supplementation in humans remains scarce and results are heterogeneous. More research needed.
Forbes spotlights longevity clinic travel, where diagnostics, biological age testing, and wellness resorts converge into destination medical tourism.